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SObjective: To determine whether the percentile quantification of emphysema with computed tomography has a
stronger association with pulmonary complications than pulmonary function testing after pulmonary lobectomy.
Methods: The patients who underwent pulmonary lobectomy and also had thin-section chest computed
tomography scans available from July 2009 through August 2011 were reviewed. The patients were divided
into 2 groups according to whether they had a history of chronic obstructive pulmonary disease. The emphysema
index (EI) was defined as the volumetric percentage of the areas of low computed tomography attenuation,
which was measured using automatic analysis software. Receiver operating characteristic curve analysis was
used to compare the predictability of pulmonary complications, and multivariate analyses were performed to
determine the risk factors for pulmonary complications.
Results: A total of 280 patients were evaluated. Pulmonary complications occurred in 37 patients (13.2%).
The median EI was 9.30 (range, 0.04-37.27). The area under the receiver operating characteristic curve was
significantly greater for the EIs than for the pulmonary function testing values. The cutoff EI value was
11.46, and the sensitivity and specificity was 83.8% and 74.1%, respectively. EI, male gender, and diffusing
capacity<80% were risk factors for pulmonary complications for all patients; EI and age>70 years were
risk factors for patients without chronic obstructive pulmonary disease; and EI and diffusing capacity<80%
were risk factors for patients with chronic obstructive pulmonary disease.
Conclusions: The EI is a significant risk factor for pulmonary complications after pulmonary lobectomy and had
stronger association with them than did pulmonary function testing. The EI might serve as a useful tool for
evaluating risk before pulmonary lobectomy. (J Thorac Cardiovasc Surg 2014;147:915-20)Pulmonary risk stratification and assessment are crucial
steps in treating patients undergoing major lung resection
surgery. Postoperative pulmonary complications, in partic-
ular, have been associated with increased mortality and
hospital costs and prolonged hospital stays, despite notable
advancements in perioperative care and surgical skill.
Various tests have been used to identify the patients at
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The Journal of Thoracic and Cabeen considered the reference standard.1-6 The predicted
values of the preoperative and postoperative forced
expiratory volume in 1 second (FEV1) and the diffusion
capacity of carbon monoxide (DLCO) have been the
2 most common parameters used for predicting
postoperative morbidity and mortality.2-6
Emphysema is a characteristic parenchymal destruction
condition that is 1 of the forms of chronic obstructive
pulmonary disease (COPD). It has been assessed in greater
detail because of major developments in multidetector
computed tomography (CT) techniques. This assessment
has been referred to as the emphysema index (EI) in many
studies. Significant correlations have been found for the EI,
pathologic emphysema grade, and PFT results.7 Thus, the
severity of the EI has been regarded as a prognostic factor
and a predictor of mortality in patients with COPD or lung
cancer in several studies.8,9 The use of the EI as a tool for
evaluating the risk of pulmonary complications after lung
resection, however, has never been reported.
The objectives of the present study were to (1) evaluate the
predictability of the EI for pulmonary complications after
pulmonary lobectomy, (2) compare the predictive values of
EIwith that of PFT, and (3) identify the significant risk factors
for pulmonary complications using multivariate analyses.rdiovascular Surgery c Volume 147, Number 3 915
TABLE 1. Baseline characteristics, demographics, comorbidities, and
operative data
Characteristic
All patients
(n ¼ 280)
Complications
(n ¼ 37)
No
complications
(n ¼ 243)
Age (y) 64.1  9.8 69.9  7.7 63.2  9.8
Age>70 y 80 (28.6) 18 (48.6) 62 (25.5)
Male gender 161 (57.5) 36 (97.3) 125 (51.4)
Smoking 137 (48.9) 31 (83.8) 106 (43.6)
Comorbidities
Pulmonary tuberculosis 37 (13.2) 5 (13.5) 32 (13.2)
Hypertension 84 (30.0) 13 (35.1) 71 (29.2)
Diabetes mellitus 28 (10.0) 6 (16.2) 22 (9.1)
COPD 109 (38.9) 28 (75.7) 81 (33.3)
Lung cancer 261 (93.2) 37 (100) 224 (92.2)
Neoadjuvant treatment 16 (5.7) 3 (8.1) 13 (5.3)
EI
Median 9.30 17.99 7.98
Range 0.04-37.27 2.26-37.27 0.04-27.88
PFT (predictive% value)
FEV1 99.7  19.4 89.9  20.0 101.1  18.9
FEV1<70% 18 (6.4) 5 (13.5) 13 (5.3)
FVC 100.5  14.8 101.4  18.4 100.3  14.2
FEV1/FVC 71.2  10.4 61.7  13.9 72.7  8.9
DLCO 95.7  19.2 87.6  20.8 96.9  18.7
DLCO<80% 57 (20.4) 16 (43.2) 41 (16.9)
Thoracotomy 109 (38.9) 22 (59.5) 87 (35.8)
VATS 171 (61.1) 15 (8.8) 156 (91.2)
Operation side
Right 174 (62.1) 25 (67.6) 149 (85.6)
Left 106 (37.9) 12 (11.3) 94 (88.7)
Data presented as mean  standard deviation, n (%), or median and range.
COPD, Chronic obstructive pulmonary disease; EI, emphysema index; PFT, pulmo-
nary function test; FEV1, forced expiratory volume in 1 second; FVC, forced vital
capacity; DLCO, diffusion capacity of carbon monoxide; VATS, video-assisted
thoracoscopic surgery.
Abbreviations and Acronyms
AUC ¼ area under the receiver operating
characteristic curve
CI ¼ confidence interval
COPD ¼ chronic obstructive pulmonary disease
DLCO ¼ diffusion capacity of carbon monoxide
EI ¼ emphysema index
FEV1 ¼ forced expiratory volume in 1 second
FVC ¼ forced vital capacity
PFT ¼ pulmonary function test
ROC ¼ receiver operating characteristics
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SMETHODS
The institutional review board reviewed the study protocol and
approved it as a minimal risk retrospective study (approval no. H-1303-
082-474). Additionally, the study did not require individual patient consent
according to the institutional guidelines for consent waivers.
A retrospective record review of a prospectively collected thoracic
database was conducted for all patients undergoing anatomic lobectomy
from July 2009 through August 2011. The present review also included
those patients who had undergone preoperative thin-section chest CT at
our institution. The following exclusion criteria were applied: bilobectomy
or pneumonectomy, previous thoracic surgery, a history of interstitial lung
disease, or concomitant resection of the diaphragm or chest wall. The
subjects were divided into 2 groups, those with and without COPD.
COPD was defined as a FEV1/forced vital capacity (FVC) ratio of<0.7.
10
All postoperative pulmonary complications were recorded prospec-
tively and were characterized as 1 of the following: atelectasis requiring
bronchoscopic toileting, pneumonia, reintubation for respiratory failure, a
requirement for tracheostomy, or acute respiratory distress syndrome.
PFT Values
Using the American Thoracic Society criteria, the PFT measurements
were performed using a spirometer (SPFS/D, MedGraphics, St Paul,
Minn) with the patients sitting in an upright position.11
The following values were evaluated: FVC, FEV1, FEV1/FVC ratio, and
DLCO. All spirometric values are expressed as a percentage of the measured
value in relation to the predicted value. All patients underwent PFTs within
1 month of surgery.
CTAcquisition Parameters
The chest CT scans were performed using the following scanners:
the Somatom Definition, Sensation-16 (Siemens Medical Solutions,
Forchheim, Germany), Brilliance-64 (Phillips Medical Systems, Best,
The Netherlands), and Discovery CT 750HD (GE Healthcare, Milwaukee,
Wis). The scanner parameters were set at 120 kVp, 100 to 200 mA, a 0.875
to 1.5 pitch, and a 1- to 1.25-mmcollimation. The CT images were acquired
after the patients had been intravenously administered a 100-mL injection
of contrast media. The images, with a thickness of 1 to 1.25 mm, were
reconstructed using a medium-sharp reconstruction algorithm. All CT
scans were obtained with each patient placed in the supine position and
at full inspiration. All patients had undergone preoperative CT scans within
1 month of surgery.
Emphysema Quantification
Themeasurements of the quantitative analysis of lung parenchymawere
obtained using an automated lung image analysis tool (Thoracic VCAR,
GE Healthcare), which was installed on an image processing workstation916 The Journal of Thoracic and Cardiovascular Surg(AWServer, version 2, GEHealthcare) for each data set. The total lung vol-
ume and EI, as represented by the relative area under a threshold of 950
Hounsfield units, were also obtained. The degree of emphysema was as-
sessed and quantified by segmenting the lung parenchyma and airways
from the chest wall and large central blood vessels. The total emphysema
percentage was defined as all lung voxels less than a certain CTattenuation
value. Previous studies have validated an attenuation threshold value of
950 Hounsfield units for the quantitative analysis of an EI (Figure 1).12
Statistical Analysis
Receiver operating characteristic (ROC) curve analysis was used to
compare the utility of PFT versus EI in predicting pulmonary complica-
tions. The areas under the ROC curves (AUCs) are presented with the
95% confidence intervals (CIs). The statistical significance of the differ-
ences in the pulmonary complication predictability was determined by
comparing the AUCs of the patients’ EIs and PFTs using nonparametric
methods previously described by DeLong and colleagues,13 followed by
Bonferroni’s adjustment. The cutoff value and sensitivity and specificity
were determined bymeasuring the point on the ROC curvewith the shortest
distance from the upper left corner. The perioperative patient characteris-
tics associated with pulmonary complications were identified by univariate
analysis. All parameters for the analysis were analyzed with parametric
(Pearson’s c2, Fisher’s exact, or Student’s t test) and nonparametricery c March 2014
FIGURE 1. Quantitative measurements of emphysema using the automated lung image analysis tool (Thoracic VCAR, GE Healthcare).
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S(Mann-WhitneyU test) tests, as applicable. The variables withP<.10 were
used as the covariates for the multivariate logistic regression analyses, with
pulmonary complications set as the dependent variable. In previous studies,
it had been demonstrated that the usefulness of PFTs in assessing operative
risk could be changed if a patient had a history of COPD; therefore,
univariate analyses and multivariate logistic regression models were
repeated separately for the groups of patients who did or did not have a
history of COPD.5 All results are presented as the mean  standard
deviation or proportions. The cutoff values from the ROC curves were
measured using MedCalc statistical software, version 8.1 (MedCalc
Software, Ostend, Belgium). Other statistical analyses were performed
using the Statistical Analysis Systems software package, version 9.2
(SAS Institute, Cary, NC).
RESULTS
During the study period, 1128 patients underwent major
lung resections. Of these patients, 280, who had undergone
pulmonary lobectomy and preoperative chest CT with the
described protocol, were included in the present study.
The excluded patients had undergone thick-section chest
CT at another hospital or other department at our center
and had been referred to us for surgery. We did not
perform additional thin-section chest CT for those patients.
The patients’ demographic data, baseline characteristics,The Journal of Thoracic and Cacomorbidities, and operative data are summarized in
Table 1. The overall operative mortality rate was 1.8%
(5 patients). The median chest tube duration for all patients
was 6 days, and the median length of hospital stay was 9
days. A total of 55 pulmonary complications occurred in
37 patients (13.2%), including pneumonia in 21 patients
(7.5%), atelectasis requiring bronchoscopic toileting in
23 (8.2%), reintubation in 5 (1.8%), tracheostomy in
2 (0.7%), and acute respiratory distress syndrome in 4
patients (1.4%). All cases of acute respiratory distress
syndrome developed secondary to pneumonia. The median
EI value was greater for the patients with pulmonary
complications (17.99 [range, 2.26-37.27] for patients with
complications vs 7.98 [range, 0.04-27.88] for those
without). The EI distributions were significantly different
between the 2 groups (P<.0001).
The ROC curve analysis is shown in Figure 2. The AUC
was 0.832 (95% CI, 0.768-0.897) for the EI, 0.741 (95%
CI, 0.644-0.837) for the FEV1/FVC ratio, 0.664 (95%
CI, 0.566-0.762) for the FEV1, and 0.632 (95% CI,
0.523-0.741) for the DLCO. The predictive power (AUC)
was significantly greater for the EI than for FEV1 andrdiovascular Surgery c Volume 147, Number 3 917
FIGURE 2. Comparison of the emphysema index (EI) and the predictive
percentage value of the pulmonary function test using a receiver operating
characteristic curve analysis. The area under the curve was 0.832 for EI,
0.741 for forced expiratory volume in 1 second (FEV1)/forced vital
capacity (FVC), 0.664 for FEV1, and 0.632 for the diffusion lung capacity
to carbon monoxide (DLCO).
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SDLCO (EI vs FEV1, P ¼ .0087; EI vs DLCO, P ¼ .0041).
The cutoff for EI with the greatest predictive ability for
pulmonary complications was 11.46, with a sensitivity
and specificity of 83.8% and 74.1%, respectively.
Significant risk factors for pulmonary complications
were identified using multivariate analysis for all studyTABLE 2. Risk factor analysis results for pulmonary complications in
all patients
Variable
Univariate Multivariate
OR (95% CI)
P
value OR (95% CI)
P
value
Thoracotomy 2.63 (1.30-5.33) .006
Age>70 y 2.77 (1.37-5.60) .004
Male gender 33.98 (4.59-251.83)<.001 19.91 (2.47-160.34) .005
EI <.001 1.13 (1.07-1.20) <.001
FEV1/FVC
<70%
6.22 (2.80-13.81) <.001
FEV1<70% 2.76 (0.92-8.27) .072
DLCO<80% 3.75 (1.81-7.80) <.001 5.72 (2.14-15.27) .001
Smoking 6.68 (2.69-16.59) <.001
Pulmonary
tuberculosis
1.000
Hypertension .464
Diabetes mellitus .176
Lung cancer 1.17 (1.11-1.22) .088
Neoadjuvant
treatment
.453
OR, Odds ratio; CI, confidence interval; FEV1, forced expiratory volume in 1 second;
DLCO, diffusion capacity of carbon monoxide; EI, emphysema index; FVC, forced
vital capacity.
918 The Journal of Thoracic and Cardiovascular Surgpatients. The EI, male gender, and DLCO <80% were
identified as significant risk factors (Table 2). When
patients were analyzed separately according to their
history of COPD, the EI and DLCO<80% were identified
as risk factors for patients with COPD, and EI and age
>70 years were identified as risk factors for patients
without COPD (Table 3).
DISCUSSION
The present study has demonstrated 2 major findings.
First, the EI had a significantly stronger association with
pulmonary complications than did the FEV1 and DLCO.
Second, patients with high EIs had a greater risk of
developing pulmonary complications after pulmonary
lobectomy, regardless of a history of COPD.
An accurate assessment of patients at a high risk of
complications after major lung resection is important
for many reasons. It could help clinicians determine
operability, obtain informed consent, and provide the
optimal treatment options to patients. Preoperative PFT
has been the most powerful tool that surgeons have used
to predict the risk of complications after major lung
resection for many decades, with FEV1 and DLCO the 2
most commonly used parameters.1-6 However, some
studies have reported that PFTs cannot accurately predict
morbidity and mortality.14,15 Many ongoing investigations
are attempting to establish the best risk-stratification model
for postoperative pulmonary complications.
Recently, interest has been renewed in the imaging of
emphysema because of improved CT detection and
quantification techniques.7 With the introduction of the
multidetector CT, it is now possible to obtain high-
resolution CT scans volumetrically for the entire lung.
This approach has been shown to be suitable for assessing
emphysema.7,16 Emphysema has been pathologically
characterized as the destruction of airways distal to the
terminal bronchioles, and it is radiologically characterized
by areas of abnormally low attenuation that contrast with
the surrounding lung parenchyma, which will have
normal CT attenuation values.7,16 Some approaches have
been made to objectively quantify emphysema using CT
scans. In the present study, we used a threshold technique
that defines emphysema by the area below a specific
threshold attenuation value.7 We set 950 HU as the
threshold attenuation value, because it has been proved to
be a valuable parameter for quantifying emphysema using
CT scans by Gevenois and colleagues.12
The clinical usefulness of emphysema quantification
by CT scan assessment (CT/emphysema quantification)
has been demonstrated in previous studies. These studies
reported good correlations between CT/emphysema
quantification and the PFT results and reported that
CT/emphysema quantification might also predict mortality
in certain patient groups.7-9,17 Stimulated by the findings ofery c March 2014
TABLE 3. Risk factor analysis results for pulmonary complications in patients with and without COPD
Variable
Patients with COPD Patients without COPD
Univariate Multivariate Univariate Multivariate
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Thoracotomy .246 4.35 (1.05-18.10) .062
Age>70 y .682 5.98 (1.51-23.69) .014 7.63 (1.47-39.60) .016
Male gender 1.42 (1.25-1.63) .011 13.97 (1.71-114.43) .003
EI <.001 1.12 (1.05-1.20) .001 .003 1.17 (1.03-1.31) .012
FEV1<70% .551 1.000
DLCO<80% 3.81 (1.50-9.67) .004 3.84 (1.19-12.40) .024 .180
Smoking history .204 8.31 (1.67-41.47) .005
Pulmonary tuberculosis .552 .284
Hypertension .726 .253
Diabetes mellitus .527 .518
Lung cancer .335 1.000
Neoadjuvant treatment 1.000 .357
COPD, Chronic obstructive pulmonary disease; OR, odds ratio; CI, confidence interval; EI, emphysema index; FEV1, forced expiratory volume in 1 second; DLCO, diffusion
capacity of carbon monoxide.
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Sthese previous studies, we hypothesized that CT/
emphysema quantification would have an intimate
relationship with pulmonary complications after lung
resection surgery if it correlated strongly with the PFT
results and predicted mortality in patients with COPD.
The present study has demonstrated that the EI
(determined from emphysema quantification by CT scan
assessment) had a significantly greater association with
pulmonary complications after pulmonary lobectomy than
did FEV1 and DLCO. Our findings are supported by those
of previously published reports that have suggested that
CT scans are more sensitive than PFTs in detecting mild
emphysema.18,19 These reports also revealed that EI
reflects the pathologic lung destruction changes before
pulmonary functions become impaired. In our study, a
number of patients had normal pulmonary function but
also had lungs with various degrees of emphysema, as
determined from their preoperative CT scans. The EI was
relatively high in this group, and some of these patients
developed pulmonary complications postoperatively.
In our study, the patients had various perioperative
characteristics (eg, thoracotomy, old age) that are proven
risk factors for pulmonary complications.3,4,6 Therefore,
we addressed whether the patients with a high EI were at
greater risk of pulmonary complications after controlling
for such confounders with logistic regression analyses.
A high EI and low DLCO were significant independent
risk factors for all study patients. This finding is
consistent with previous reports, in which DLCO was an
independent significant risk factor for pulmonary
complications.1,2,4-6 In a subgroup analysis, a high EI
and old age were significant risk factors for pulmonary
complications in patients without COPD; however, high
EI and low DLCO were determined to be significant in
patients with COPD. In keeping with the ROC curveThe Journal of Thoracic and Caanalysis results, we found that EI was an independent
significant risk factor for predicting pulmonary
complications, regardless of COPD history.
The present study had some limitations that must be
acknowledged. First, our study was a retrospective review
from a single institution. Randomized controlled or
prospective study designs would be necessary to solidify
the findings from our study. Second, the EI has not been
validated in any other previous studies. It must be validated
to exhibit its predictability for pulmonary complications
after major lung resection. Third, our study group only
included patients who had undergone lobectomy. To prove
its usability in the preoperative risk assessment for major
lung resection, patients undergoing bilobectomy and
pneumonectomy should be included in future studies.
Fourth, the section thickness and CT scanners were not
standardized in the present study. Nevertheless, because
all patients underwent thin-section CT scans (ranging from
1 to 1.25 mm in thickness), we assumed only subtle differ-
ences would be present in the emphysema quantifications.
Although the effect of the CT scanners did not significantly
influence the CT/emphysema quantification in some
previous studies, we would recommend standardizing the
CT scanners in future studies for a more accurate
analysis.20,21 Fifth, all patients were exposed to a standard
radiation dose for their CT scan with intravenous contrast
media. It has been reported that the radiation dose and
contrast media could affect emphysema quantification and
that a low-radiation-dose CT scan without contrast media
has been shown to have the least effect on emphysema quan-
tification.22,23Although the radiation dose and the amount of
contrast media were standardized for all patients in the
present study, we would recommend performing low-dose
CT scans without intravenous contrast media to more
accurately quantify emphysema in future studies.rdiovascular Surgery c Volume 147, Number 3 919
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SCONCLUSIONS
From the results of our study, we would recommend
using the EI from a preoperative CT scan for patients
undergoing pulmonary lobectomy to help clinicians more
accurately evaluate those who might be at high risk of
developing pulmonary complications. The EI has high
reproducibility and is easy to calculate using automatic
analysis software; therefore, we believe that it will serve
as a valuable tool in risk evaluation before pulmonary
lobectomy for thoracic surgeons.24 Nevertheless, because
our study also demonstrated that both EI and low DLCO
were significant risk factors for pulmonary complications
(consistent with previous reports), clinicians must consider
the EI in combination with PFTs for a more accurate
preoperative risk evaluation.
The authors thank Min-Jeong Yun from the General Electronics
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